Related Experiment Video
Updated: May 15, 2025

09:09
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
Published on: June 23, 2020
5.9K
Metal coordination polymer nanoparticles for cancer therapy
Zhengzheng Zhang1, Isra Rana1, Jutaek Nam1
1College of Pharmacy, Chonnam National University, Gwanju 61186, South Korea.
Essays in Biochemistry
|April 10, 2025
Summary
Metal ions show promise for cancer therapy but face delivery challenges. Metal coordination polymer nanoparticles (MCP NPs) offer a solution, improving metal ion delivery and reducing toxicity for enhanced cancer treatment.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapeutics
Background:
- Metal ions are crucial for biological processes and immune homeostasis, with potential in cancer therapy.
- However, their physicochemical properties limit effective delivery and increase toxicity in cancer treatment.
- Metal coordination polymer nanoparticles (MCP NPs) emerge as a promising nanoplatform to overcome these limitations.
Purpose of the Study:
- To review the biological roles of metal ions in cancer therapy.
- To explore the application of MCP NPs for improved metal ion delivery in preclinical cancer models.
- To highlight the design principles of MCP NPs for enhanced therapeutic outcomes.
Main Methods:
- Comprehensive literature review of metal ion functions in cancer.
- Analysis of MCP NP systems for drug delivery in cancer therapy.
- Examination of metal ion engineering strategies within MCP NPs.
Main Results:
- Metal ions can induce cancer cell death and stimulate antitumor immune responses.
- MCP NPs improve the pharmacological performance and reduce toxicity of metal ions.
- Versatile engineering of MCP NPs allows for tailored nano-drug designs.
Conclusions:
- MCP NPs represent a significant advancement in metal ion-based cancer therapy.
- These nanoparticles enhance therapeutic efficacy and minimize side effects.
- MCP NPs offer a versatile platform for developing next-generation cancer treatments.

